Columbia Laboratories (CBRX) 6.11 $CBRX
Columbia Laboratories posts lower net income of USD0.2m for Q2 2014
M2 - Fri Aug 01, 8:16AM CDT
Pharmaceutical company Columbia Laboratories (NasdaqCM:CBRX) stated on Thursday its net income of USD0.2m, or USD0.01 per diluted share, for the three month period ended 30 June 2014.
Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis
PR Newswire - Thu Jul 31, 6:00AM CDT
Columbia Laboratories, Inc. (NASDAQ: CBRX) today announced that its subsidiary, Molecular Profiles Ltd., and XenoGesis Ltd., have announced a collaboration that will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage. Molecular Profiles' pharmaceutical development services will be supported by XenoGesis' expertise in preclinical drug metabolism and pharmacokinetics (DMPK) to give clients a smarter route into formulation development and a better understanding of a compound's bioavailability. This strategic alliance will allow the Nottingham-based companies to help drug developers in the initial design and selection of compounds for key DMPK and ADME (absorption, distribution, metabolism and elimination) studies, as well as supporting lead candidates which have solubility issues during formulation development.
Columbia Laboratories Reports Second Quarter 2014 Financial Results
PR Newswire - Thu Jul 31, 6:00AM CDT
Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"
today announced financial results for the three and six-month periods ended June 30, 2014.
Columbia Laboratories Up 11.8% Since SmarTrend Uptrend Call (CBRX)
Comtex SmarTrend(R) - Fri Jul 25, 9:59AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 12 months, Columbia Laboratories has returned 11.82% as of today's recent price of $6.29.
Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call
PR Newswire - Wed Jul 23, 7:30AM CDT
The management team at Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on July 31, 2014, to discuss financial results for the second quarter ended June 30, 2014. The call details are as follows:
Uptrend Call Working As Columbia Laboratories Stock Rises 10.4% (CBRX)
Comtex SmarTrend(R) - Fri Jul 18, 9:31AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 11 months, Columbia Laboratories has returned 10.40% as of today's recent price of $6.21.
Columbia Laboratories expands intellectual property portfolio with new patent for extended release delivery system of drugs
M2 - Fri Jul 18, 8:58AM CDT
Pharmaceutical company Columbia Laboratories (NasdaqCM:CBRX) disclosed on Thursday the expansion of its intellectual property portfolio with the issue of a new patent covering its bioadhesive progressive hydration tablets.
Columbia Laboratories Expands its Intellectual Property Portfolio Following Receipt of U.S. Patent
PR Newswire - Thu Jul 17, 7:30AM CDT
Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company" , a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it has expanded its intellectual property portfolio following the receipt of a patent covering bioadhesive progressive hydration tablets. The issued patent, U.S. Patent 8,765,177, pertains to a controlled, extended release delivery system for pharmaceutical compounds and can be used by the Company to develop proprietary products.
Shares of CBRX Up 10.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 4:57PM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 11 months, Columbia Laboratories has returned 10.58% as of today's recent price of $6.22.
18.6% Return Seen to Date on SmarTrend Columbia Laboratories Call (CBRX)
Comtex SmarTrend(R) - Thu Jun 26, 9:52AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 11 months, Columbia Laboratories has returned 18.58% as of today's recent price of $6.67.
Columbia Laboratories Added to the Russell Microcap Index
PR Newswire - Thu Jun 26, 7:00AM CDT
Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company" , a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it has been added to the preliminary list for the Russell Microcap Index, to be finalized on June 27, 2014. The new membership lists for Russell Indexes are available at http://www.russell.com/indexes/tools-resource...tution.asp.
Columbia Laboratories Up 20.5% Since SmarTrend Uptrend Call (CBRX)
Comtex SmarTrend(R) - Thu Jun 19, 9:20AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 10 months, Columbia Laboratories has returned 20.53% as of today's recent price of $6.78.
Columbia Laboratories Has Returned 18.8% Since SmarTrend Recommendation (CBRX)
Comtex SmarTrend(R) - Wed Jun 11, 5:10PM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 10 months, Columbia Laboratories has returned 18.76% as of today's recent price of $6.68.
Uptrend Call Working As Columbia Laboratories Stock Rises 32.6% (CBRX)
Comtex SmarTrend(R) - Thu Mar 20, 9:17AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 7 months, Columbia Laboratories has returned 32.62% as of today's recent price of $7.46.
Columbia Laboratories Shares Up 27.8% Since SmarTrend's Buy Recommendation (CBRX)
Comtex SmarTrend(R) - Wed Mar 12, 5:02PM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 7 months, Columbia Laboratories has returned 27.82% as of today's recent price of $7.19.
Columbia Laboratories posts lower net income of USD0.2m for Q2 2014
M2 - Fri Aug 01, 8:16AM CDT
Pharmaceutical company Columbia Laboratories (NasdaqCM:CBRX) stated on Thursday its net income of USD0.2m, or USD0.01 per diluted share, for the three month period ended 30 June 2014.
Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis
PR Newswire - Thu Jul 31, 6:00AM CDT
Columbia Laboratories, Inc. (NASDAQ: CBRX) today announced that its subsidiary, Molecular Profiles Ltd., and XenoGesis Ltd., have announced a collaboration that will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage. Molecular Profiles' pharmaceutical development services will be supported by XenoGesis' expertise in preclinical drug metabolism and pharmacokinetics (DMPK) to give clients a smarter route into formulation development and a better understanding of a compound's bioavailability. This strategic alliance will allow the Nottingham-based companies to help drug developers in the initial design and selection of compounds for key DMPK and ADME (absorption, distribution, metabolism and elimination) studies, as well as supporting lead candidates which have solubility issues during formulation development.
Columbia Laboratories Reports Second Quarter 2014 Financial Results
PR Newswire - Thu Jul 31, 6:00AM CDT
Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"
today announced financial results for the three and six-month periods ended June 30, 2014. Columbia Laboratories Up 11.8% Since SmarTrend Uptrend Call (CBRX)
Comtex SmarTrend(R) - Fri Jul 25, 9:59AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 12 months, Columbia Laboratories has returned 11.82% as of today's recent price of $6.29.
Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call
PR Newswire - Wed Jul 23, 7:30AM CDT
The management team at Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on July 31, 2014, to discuss financial results for the second quarter ended June 30, 2014. The call details are as follows:
Uptrend Call Working As Columbia Laboratories Stock Rises 10.4% (CBRX)
Comtex SmarTrend(R) - Fri Jul 18, 9:31AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 11 months, Columbia Laboratories has returned 10.40% as of today's recent price of $6.21.
Columbia Laboratories expands intellectual property portfolio with new patent for extended release delivery system of drugs
M2 - Fri Jul 18, 8:58AM CDT
Pharmaceutical company Columbia Laboratories (NasdaqCM:CBRX) disclosed on Thursday the expansion of its intellectual property portfolio with the issue of a new patent covering its bioadhesive progressive hydration tablets.
Columbia Laboratories Expands its Intellectual Property Portfolio Following Receipt of U.S. Patent
PR Newswire - Thu Jul 17, 7:30AM CDT
Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"
, a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it has expanded its intellectual property portfolio following the receipt of a patent covering bioadhesive progressive hydration tablets. The issued patent, U.S. Patent 8,765,177, pertains to a controlled, extended release delivery system for pharmaceutical compounds and can be used by the Company to develop proprietary products. Shares of CBRX Up 10.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 4:57PM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 11 months, Columbia Laboratories has returned 10.58% as of today's recent price of $6.22.
18.6% Return Seen to Date on SmarTrend Columbia Laboratories Call (CBRX)
Comtex SmarTrend(R) - Thu Jun 26, 9:52AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 11 months, Columbia Laboratories has returned 18.58% as of today's recent price of $6.67.
Columbia Laboratories Added to the Russell Microcap Index
PR Newswire - Thu Jun 26, 7:00AM CDT
Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"
, a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it has been added to the preliminary list for the Russell Microcap Index, to be finalized on June 27, 2014. The new membership lists for Russell Indexes are available at http://www.russell.com/indexes/tools-resource...tution.asp. Columbia Laboratories Up 20.5% Since SmarTrend Uptrend Call (CBRX)
Comtex SmarTrend(R) - Thu Jun 19, 9:20AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 10 months, Columbia Laboratories has returned 20.53% as of today's recent price of $6.78.
Columbia Laboratories Has Returned 18.8% Since SmarTrend Recommendation (CBRX)
Comtex SmarTrend(R) - Wed Jun 11, 5:10PM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 10 months, Columbia Laboratories has returned 18.76% as of today's recent price of $6.68.
Uptrend Call Working As Columbia Laboratories Stock Rises 32.6% (CBRX)
Comtex SmarTrend(R) - Thu Mar 20, 9:17AM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 7 months, Columbia Laboratories has returned 32.62% as of today's recent price of $7.46.
Columbia Laboratories Shares Up 27.8% Since SmarTrend's Buy Recommendation (CBRX)
Comtex SmarTrend(R) - Wed Mar 12, 5:02PM CDT
SmarTrend identified an Uptrend for Columbia Laboratories (NASDAQ:CBRX) on August 9th, 2013 at $5.63. In approximately 7 months, Columbia Laboratories has returned 27.82% as of today's recent price of $7.19.
